The Pharmaceutical Society of Australia (VIC. branch) and the Primary Health Networks Alliance are hosting a hepatitis C information event for pharmacists, including by webinar at regional PSA satellite centers
When: Tuesday, 8 November 2016
Where: 381 Royal Parade, Parkville 3052, and Regional and Satellite Centres (see flyer for location details)
Cost: FREE for all pharmacists
Time: 7:00pm Networking and Refreshments, 7:30pm to 9:00pm Lecture
October 17, 2016 • hapn staff
A number of full and partial scholarships have been announced for the 4th International Symposium on Hepatitis Care in Substance Users (INHSU) Conference, Sydney, October 7-9 2015.
Scholarships will be granted to New Investigators (currently enrolled in BSc, PHD or Masters Degree) and Community-Based Individuals (working or volunteering in a drug user organisation or a grassroots-non government organisation).
Applications close Friday 12 June for New Investigator scholarships and Friday June 26 for Community-Based scholarships. More information is available at the conference website.
via the Centre for Research Excellence into Injecting Drug Use
June 4, 2015 • hapn staff
The Latrobe Community Health Service with Primary Care Connect is please to announce the immediate availability of Nurse Practitioner scholarships.
Scholarships of up to $10,000 per annum are available to support nurse practitioner candidates or endorsed who wish to undertake academic study or research to enhance their capacity to treat drug and alcohol clients, including with pharmacotherapy.
Examples of what the grant may be used for include:
Scholarships applications are open to all Nurse Practitioners practising within the Gippsland or Hume area.
Guidelines and an application form may be accessed via the following links.
May 26, 2015 • hapn staff
The Hume Area Pharmacotherapy Network is pleased to present an evening education session in Wangaratta on May 21.
A.Prof. Mike McDonough is a specialist in addiction medicine and director of the Addiction Medicine & Toxicology Unit at Western Health. He provides education and support services in pharmacotherapy to the Hume region via the Rural Addiction Medicine Pharmacotherapy Specialist service (RAMPS). Mike will speak on managing the risks associated with prescribing opioid medications, recognising the potential for abuse and diversion and minimising harm whilst maintaining access to appropriate treatment.
Download an event information sheet and register today. Places are limited and will fill quickly.
May 1, 2015 • hapn staff
The latest VAADA enews highlights the 2014 NOPSAD report ahead of the June 2015 snapshot.
Dependence on opioid drugs such as heroin or morphine is associated with a range of health and social problems that affect individual drug users, their family and friends, and the wider public. Treatment with an opioid pharmacotherapy drug, such as methadone or buprenorphine, can reduce drug cravings (NDARC 2004) and improve physical and mental health and social and economic participation, including a reduction in drug-related crime (Ritter & Chalmers 2009).
The National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) collection provides information on a snapshot day in June 2014 on clients receiving opioid pharmacotherapy treatment, the doctors prescribing opioid pharmacotherapy drugs, and the dosing points (such as pharmacies) that clients attend to receive their medication.
Following are highlights from the NOPSAD collection. Further information will be released in June 2015.
Highlights from the 2014 collection
•2 in 3 were male.
•Median age was 40 and is increasing.
•1 in 10 identified as being Aboriginal and/or Torres Strait Islander.
•Heroin was the most common opioid drug of dependence for which treatment was sought.
•2 in 3 were treated with methadone.
•82% worked in the private sector.
•74% were authorised to prescribe more than 1 type of pharmacotherapy drug.
•21 clients on average were treated by each prescriber.
•88% were pharmacies.
•20 clients on average were dosed at each dosing point.
The NOPSAD collection commenced in 2005 and comprises data about the clients receiving opioid pharmacotherapy treatment and the dosing point site where treatment is provided, for all registered or authorised prescribers of pharmacotherapy drugs. Data are collected by state and territory health departments and reported to the AIHW. Prior to 2005, information was provided each year to the Australian Government Department of Health.
Link to original VAADA enews:
Link to more information at:
April 24, 2015 • hapn staff
The hapn Twitter feed is now active!
Visit us at @hapn_news or use the feed to the left to get your hapn news. Education events, updates to guidelines and policy and other related drug and alcohol news will be featured.
January 12, 2015 • hapn staff
We are thrilled to announce the launch of the Hume Area Pharmacotherapy Network website, hapn.org.au
Drawing content from many sources, the website has been set up as a gateway for medical practitioners, pharmacists, nurses and other key workers looking for service contacts, resources, education and CPD events relevant to providing pharmacotherapy services in the Hume area of Victoria.
The new site is divided into three key sections:
Additionally, the website provides relevant news from several sources, including from hapn’s own Twitter feed @hapn_news.
The hapn website has been built to be accessible on all devices, from mobile to desktop, including screen reading devices. Please report any issues you have using this website to email@example.com
January 9, 2015 • hapn staff